Evrofarma SA (ATH:EVROF)
Greece flag Greece · Delayed Price · Currency is EUR
3.610
-0.070 (-1.90%)
Apr 28, 2026, 5:10 PM EET

Evrofarma Revenue

In the year 2025, Evrofarma had annual revenue of 49.44M EUR with 8.14% growth. Evrofarma had revenue of 24.32M in the half year ending June 30, 2025, a decrease of -5.30%.

Revenue
49.44M
Revenue Growth
+5.55%
P/S Ratio
1.00
Revenue / Employee
297.84K
Employees
210
Market Cap
49.36M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202549.44M3.72M8.14%
Dec 31, 202445.72M-3.04M-6.24%
Dec 31, 202348.76M3.38M7.45%
Dec 31, 202245.38M8.68M23.66%
Dec 31, 202136.70M2.79M8.23%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Karelia Tobacco Company 315.78M
Gr. Sarantis 599.56M
Kri-Kri Milk Industry 328.82M
Papoutsanis 79.86M
MIG Holdings 13.75M
Loulis Food Ingredients 206.06M
Mediterra 14.25M
Flour Mills C. Sarantopoulos 14.11M
Revenue Rankings